Stay updated on Pembrolizumab+Chemoradiotherapy in Muscle-Invasive Bladder Ca Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+Chemoradiotherapy in Muscle-Invasive Bladder Ca Clinical Trial page.

Latest updates to the Pembrolizumab+Chemoradiotherapy in Muscle-Invasive Bladder Ca Clinical Trial page
- CheckyesterdayChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.7%
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check22 days agoChange DetectedThe web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check51 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check65 days agoChange DetectedThe page has undergone significant updates, including the addition of new collaborators and investigators related to a study on bladder cancer, as well as a revision update from v2.14.4 to v2.15.0. Notably, detailed information about the study's patient enrollment criteria and treatment protocols has been removed.SummaryDifference43%
- Check72 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to January 27, 2025.SummaryDifference0.4%
Stay in the know with updates to Pembrolizumab+Chemoradiotherapy in Muscle-Invasive Bladder Ca Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Chemoradiotherapy in Muscle-Invasive Bladder Ca Clinical Trial page.